Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus - Wikidata - wikimedia - TriplyDB

Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus

Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus

http://www.wikidata.org/entity/Q34057324

about

Multifaceted Interfaces of Bacterial Competition.Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.Adaptive resistance to antibiotics in bacteria: a systems biology perspective.

P2860

Q36035660-896F8406-072B-4524-BE34-8265E21F8994 Q36158472-287346CD-B218-49C2-A76E-AABC85E9AC72 Q38814607-07E040F8-8B22-454E-B912-8C5E4A4AE8D8

P2860

Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus

http://www.wikidata.org/entity/Q34057324

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Exposure of Staphylococcus aur ...... rmediate Staphylococcus aureus

@ast

Exposure of Staphylococcus aur ...... rmediate Staphylococcus aureus

@en

Exposure of Staphylococcus aur ...... rmediate Staphylococcus aureus

@nl

type

label

Exposure of Staphylococcus aur ...... rmediate Staphylococcus aureus

@ast

Exposure of Staphylococcus aur ...... rmediate Staphylococcus aureus

@en

Exposure of Staphylococcus aur ...... rmediate Staphylococcus aureus

@nl

prefLabel

Exposure of Staphylococcus aur ...... rmediate Staphylococcus aureus

@ast

Exposure of Staphylococcus aur ...... rmediate Staphylococcus aureus

@en

Exposure of Staphylococcus aur ...... rmediate Staphylococcus aureus

@nl

P1433

Q34057324-AAD19B87-01CC-4501-AFAD-DB3EE0BA154A

P1476

Q34057324-39C05386-CB3D-4B37-8576-F95402A783CC

P2093

Q34057324-3246AEE1-C8DA-4D77-A4CD-455EF388557F

Q34057324-44FCB3DF-FC47-48E5-84EC-96AADEFBF7C1

Q34057324-53450B51-D5B6-4903-93B5-6CC5B818C444

Q34057324-D5855EF1-00B9-40CF-8DC4-76123C840932

Q34057324-D91EC762-8CA0-44D2-8ADF-5D7E92AA1BA5

Q34057324-E3AC5540-2C11-4CE1-A4EE-95A2F6915B90

Q34057324-F7871B0C-EC42-4972-B0B9-9557413C2D59

Q34057324-FE439138-002D-434C-AC93-989B1C6C0265

P2860

Q34057324-05E5FF30-E925-4B03-B403-6E5FB079780B

Q34057324-13E1718E-0AE1-43CA-B96C-61EFD123481A

Q34057324-2AA966F3-92A6-45C5-ABC2-CA37113E044F

Q34057324-2EA897E9-4DEB-4E0E-8DB5-89EB78C47C2B

Q34057324-30F66123-25A7-427D-8990-0ADCFAFC00FA

Q34057324-45B90AF2-0DDE-4C1D-8C28-29A2ECD3F701

Q34057324-4A44184F-58FB-41D7-BF4A-DAD8E78CFDFD

Q34057324-4E44C63B-2104-4B93-B655-40672B3B1311

Q34057324-578CFE56-ACA1-45DA-99C2-F14F35A8E3FE

Q34057324-57AC2699-795E-4497-97A9-7421FC4CD304

P304

Q34057324-184B4227-9F03-41B5-A50B-F3938360124F

P31

Q34057324-8ACE2FBF-3EFE-4B52-AC6C-FB3AD733F27E

P356

Q34057324-88801F92-5629-432E-8A5C-09A8AFA52EEB

P407

Q34057324-8A3C0879-5815-4FAC-8972-9B0B98463DB6

P433

Q34057324-753EC292-D46F-4A16-89D1-BA26E81D197E

P478

Q34057324-90FD64C8-85F2-460C-AD11-417BF4D7D7F6

P50

Q34057324-1005F88D-50B5-488E-A1B2-06DA3E6A7B23

Q34057324-7C3076EF-2C9B-4FE4-9024-276152F214A3

Q34057324-8F418CEB-85C5-4B78-8248-1D734D6F1738

Q34057324-BBF948DB-6F99-4F96-A52D-12B250599104

P577

Q34057324-DB9F94A9-520F-41FA-9C53-53B6B449E062

P5875

Q34057324-8849B8B4-751A-4EE2-A37B-569C59135E97

P698

Q34057324-4886A0DF-4586-4DC0-8C02-D32E44B7DD7C

P921

Q34057324-C2844C3A-E4F4-4A71-9182-7564D57D3F6A

P932

Q34057324-03153224-2E68-42BF-9C0F-4C6C05972ED3

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Exposure of Staphylococcus aur ...... rmediate Staphylococcus aureus

@en

P2093

Adriana Renzoni

http://www.w3.org/2001/XMLSchema#string

Anne-Marie Freydière

http://www.w3.org/2001/XMLSchema#string

Annie Martra

http://www.w3.org/2001/XMLSchema#string

Marie-Elisabeth Reverdy

http://www.w3.org/2001/XMLSchema#string

Michèle Bes

http://www.w3.org/2001/XMLSchema#string

Mélanie Roch

http://www.w3.org/2001/XMLSchema#string

Perrine Clair

http://www.w3.org/2001/XMLSchema#string

Philippe Reix

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications

Basic local alignment search tool

MurAA, catalysing the first committed step in peptidoglycan biosynthesis, is a target of Clp-dependent proteolysis in Bacillus subtilis

Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates

Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative.

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.

Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).

Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus

Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis.

Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods.

P304

5306-5314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02574-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Francois Vandenesch

Oana Dumitrescu

Frederic Laurent

Olivier Dauwalder

P577

2014-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263356952

http://www.w3.org/2001/XMLSchema#string

P698

24957836

http://www.w3.org/2001/XMLSchema#string

P921

P932

4135816

http://www.w3.org/2001/XMLSchema#string